Literature DB >> 27413317

Evaluation of s.c. route of immunization by homologous radio attenuated live vaccine in experimental murine model of visceral leishmaniasis.

Sanchita Datta1, Supriya Khanra1, Anindita Chakraborty2, Syamal Roy3, Madhumita Manna1.   

Abstract

Our previous studies in BALB/c mice showed substantial protection against the experimental murine visceral leishmaniasis (MVL) when the animals were immunized with γ-irradiated live Leishmania donovani parasites through intra peritoneal (i.p.) and intra muscular (i.m.) routes respectively. The observations encouraged us to check the prophylactic efficacy of subcutaneous (s.c.) route as it is better alternative for human trial. The mice immunized with two subsequent doses of the radio attenuated homologous vaccine were challenged with virulent L. donovani parasites. Seventy-five days post infection, the animals were sacrificed. The extent of protection against the disease was evaluated by assessing the reduction of parasite burden in spleen and liver, the generation of free radicals (NO & ROS) and release of the cytokines from T-lymphocyte helper 1 (Th 1) and T-lymphocyte helper 2 (Th 2) along with the measurement of the serum immunoglobulins. The reductions in parasitic burden were observed up to 21 and 24 % in spleen and liver of the immunized groups with NO and ROS productions 27 and 34 % respectively. Whereas the increase in IFN gamma releases was between 19 and 34 %, the decrease in IL-10 release was not more than 22 %. This indicates the failure of the establishment of pronounced Th1 ambience which was further corroborated by the observed IgG2a and IgG1 ratio. The present study when compared with our previous observations with i.m. and i.p. routes revealed that s.c. route may not be a good choice for the use of radio attenuated vaccine.

Entities:  

Keywords:  NO/ROS; Radio attenuated vaccine; Routes of homologous immunization; Th1/Th2 cytokines; Visceral leishmaniasis

Year:  2014        PMID: 27413317      PMCID: PMC4927504          DOI: 10.1007/s12639-014-0522-7

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  36 in total

1.  Some aspects of immunity to intracellular protozoan parasites.

Authors:  L A STAUBER
Journal:  J Parasitol       Date:  1963-02       Impact factor: 1.276

2.  Radio-attenuated leishmanial parasites as immunoprophylactic agent against experimental murine visceral leishmaniasis.

Authors:  Sanchita Datta; Rupchand Adak; Priyanka Chakraborty; Arun Kumar Haldar; Surajit Bhattacharjee; Anindita Chakraborty; Syamal Roy; Madhumita Manna
Journal:  Exp Parasitol       Date:  2011-10-12       Impact factor: 2.011

3.  Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation.

Authors:  S L Constant; K S Lee; K Bottomly
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

4.  Vaccine development against cutaneous leishmaniasis. Subcutaneous administration of radioattenuated parasites protects CBA mice against virulent Leishmania major challenge.

Authors:  D Rivier; R Shah; P Bovay; J Mauel
Journal:  Parasite Immunol       Date:  1993-02       Impact factor: 2.280

5.  Influence of the inoculation route in BALB/c mice infected by Leishmania infantum.

Authors:  Nuno Rolão; Cláudia Melo; Lenea Campino
Journal:  Acta Trop       Date:  2004-03       Impact factor: 3.112

6.  IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.

Authors:  Samiran Saha; Smriti Mondal; Rajesh Ravindran; Swati Bhowmick; Dolanchampa Modak; Sudeshna Mallick; Mehboobar Rahman; Sourjya Kar; Ramaprasad Goswami; Subhasis Kamal Guha; Netai Pramanik; Bibhuti Saha; Nahid Ali
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

7.  Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.

Authors:  F Y Liew; C Hale; J G Howard
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

8.  Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response.

Authors:  G S Nabors; J P Farrell
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.

Authors:  H W Murray; C F Nathan
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

10.  Activation of human macrophages. Comparison of other cytokines with interferon-gamma.

Authors:  C F Nathan; T J Prendergast; M E Wiebe; E R Stanley; E Platzer; H G Remold; K Welte; B Y Rubin; H W Murray
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.